Modulation of costimulatory molecules on follicular lymphoma cells by TNF and CD40

Leukemia and Lymphoma

Volumn 33, Issue 3-4, 1999, Pages 331-341

  Renard, Nathalie ^a   Ribeiro, Patricia ^a   Warzocha, Krzysztof ^a   Rouvière, Rosemonde ^a   Charlot, Carole ^a   Coiffier, Bertrand ^a   Salles, Gilles ^a  

^a CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Anti tumor immunity; CD27; CD40; CD80; CD86; Co stimulatory molecules; Lymphoma; Tumor necrosis factor

Indexed keywords

B7 ANTIGEN; CD27 ANTIGEN; CD40 ANTIGEN; CD70 ANTIGEN; CD86 ANTIGEN; GLYCOPROTEIN GP 39; TUMOR NECROSIS FACTOR;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DNA TRANSFECTION; FEMALE; FOLLICULAR LYMPHOMA; HUMAN; HUMAN TISSUE; L CELL; MALE; PRIORITY JOURNAL;

EID: 0032916698     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199909058433     Document Type: Article

References (47)

1. Liu, Y.J. and Banchereau, J. (1997) Regulation of B-cell commitment to plasma cells or to memory B cells. Seminars in Immunology, 9, 235-240.
2. Bazzoni, F. and Beutler, B. (1996) The Tumor Necrosis Factor Ligand and Receptor Family. New England Journal of Medicine, 334, 1717-1725.
3. Beutler, B.. (1992) Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine. New-York, NY: Raven Press, Ltd.
4. Warzocha, K., Bienvenu, J., Coiffier, B. and Salles, G. (1994) Mechanisms of Action of the Tumor Necrosis Factor and Lymphotoxin Ligand-Receptor System. European Cytokine Network, 5, 83-96.
5. Aggarwal, B. and Natarajan, K. (1996) Tumor Necrosis Factors: Developments During the Last Decade. European Cytokine Network, 7, 93-124.
6. Pasparakis, M., Alexopoulo, L., Episkopoulo, V. and Kollias, G (1996) Immune and Inflammatory Responses in TNFα-deficient Mice: A Critical Requirement for TNFα in the Formation of Primary B Cell Follicules, Follicular Dendritic Cell Networks and Germinal Centers, and in the Maturation of the Humoral Immune Response. Journal of Experimental Medicine, 184, 1397-1411.
7. Matsumoto, M., Mariathasan, S., Nahm, M.H., Baranyay, F., Peschon, J.J. and Chaplin, D.D. (1996) Role of Lymphotoxin and Type I TNF Receptor in the Formation of Germinal Centers. Science, 271, 1289-1291.
8. Liu, Y.-J. and Banchereau, J. (1996) Mutant Mice Without B Lymphocytes Follicles. Journal of Experimental Medicine, 184, 1207-1211.
9. Harris, N.L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.C.K., Cleary, M.L., Delsol, G., de Wolf-Peeters, C., Falini, B., Gatter, K.C., Grogan, T.M., Isaacson, P.G., Knowles, D.M., Mason, D.Y., Muller-Hermelink, H.-K., Pileri, S.A., Piris, M.A., Ralfkiaer, E. and Warnke, R.A. (1994) A Revised European-American Classification of Lymphoid Neoplasms: A proposal From the International Lymphoma Study Group. Blood, 84, 1361-1392.
10. Yang, E. and Korsmeyer, S. (1996) Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood, 88, 386-401.
11. Townsend, S.E. and Allison, J.P. (1993) Tumor Rejection After Direct Costimulation of CD8+ T Cells by B7-Transfected Melanoma Cells. Science, 259, 368-370.
12. Lenschow, D.J., Walunas, T.L. and Bluestone, J.A. (1996) CD28/B7 System of T Cell Costimulation. Annual Review in Immunology, 14, 233-258.
13. Salles, G., Bienvenu, J., Bastion, Y., Barbier, Y., Doche, C., Warzocha, C., Gutowski, M.-C., Rieux, C. and Coiffier, B. (1996) Elevated Circulating Levels of TNFα and its P55 Receptor are Associated with an Adverse Prognosis in Lymphoma Patients. British Journal of Haematology, 93, 352-359.
14. Warzocha, K., Salles, G., Bienvenu, J., Bastion, Y., Dumontet, C., Renard, N., Neidhardt, E.-M. and Coiffier, B. (1997) Tumor Necrosis Factor Ligand-Receptor System Can Predict Treatment Outcome in Lymphoma Patients. Journal of Clinical Oncology, 15, 499-508.
15. Ryffel, B., Brockhaus, M., Durmuller, U. and Gudat, F. (1991) Tumor necrosis factor receptors in lymphoid tissues and lymphomas. Source and site of action of tumor necrosis factor alpha. American Journal of Pathology, 139, 7-15.
16. Sappino, A.-P., Seelentag, W., Pelte, M.-F., Alberto, P. and Vassali, P. (1990) Tumor Necrosis Factor/Cachectin and Lymphotoxin Gene Expression in Lymph Nodes Lymphoma Patients. Blood, 75, 958-962.
17. Gruss, H.-J. and Dower, S. (1995) Tumor Necrosis Factor Ligand Superfamily: Involvement in the pathology of malignant lymphomas. Blood, 85, 3378-3404.
18. Trentin, L., Zambello, R., Agostini, C., Siviero, F., Adami, F., Marcolongo, R., Raimondi, R., Chisesi, T., Pizzolo, G. and Semenzato, G. (1993) Expression and functional role of tumor necrosis factor receptors on leukemic cells from patients with type B chronic lymphoproliferative disorders. Blood, 81, 752-758.
19. Ranheim, E.A. and Kipps, T.J. (1995) Tumor necrosis factor-alpha facilitates induction of CD80 (B7-1) and CD54 on human B cells by activated T cells: complex regulation by IL-4, IL-10, and CD40L. Cellular Immunology, 161, 226-235.
20. Garrone, P., Neidhardt, E.-M., Garcia, E., Galibert, L., van Kooten, C. and Banchereau, J. (1996) Fas Ligation Induces Apoptosis of CD40-Activated Human B lymphocytes. Journal of Experimental Medicine, 182, 1265-1273.
21. Vallé, A., Garrone, P., Yssel, H., Bonnefoy, J.-Y., Freedman, A.S. and Nadler, L.M. (1990) mAb 104, a New Monoclonal Antibody, recognizes the B7 Antigen that is Expressed on Activated B Cells and HTLV-1-Transformed T Cells. Immunology, 69, 531-535.
22. Azuma, M., Ito, D., Yagita, H., Okumura, K., Philipps, J.H., Lanier, L.L. and Somoza, C. (1993) B70 Antigen is a Second Ligand for CTLA-4 and CD28. Nature, 366, 76-79.
23. Stack, R.M., Lenshow, D.J., Gray, G.S., Bluestone, J.A. and Fitch, F.W. (1994) IL-4 Treatment of Small Splenic B Cells Induces Costimulatory Molecules B7.1 and B7.2. Journal of Immunology, 152, 5723-5733.
24. Roy, M., Aruffo, A., Ledbetter, J., Kerhy, M. and Noelle, R. (1995) Studies on the Interdependence of gp39 and B7 Expression and Function During Antigen-specific Immune Response. European Journal of Immunology, 25, 596-603.
25. Yang, Y. and Wilson, J.M. (1996) CD40 Ligand-Dependent T cell Activation: Requirement of B7-CD28 Signaling through CD40. Science, 273, 1862-1864.
26. Ranheim, E.A., Cantwell, M.J. and Kipps, T.J. (1995) Expression of CD27 and its ligand, CD70, on chronic lymphocytic leukemia B cells. Blood, 85, 3556-3565.
27. Lens, S.M., de Jong, R., Hooibrink, B., Koopman, G., Pals, S.T., van Oers, M.H. and van Lier, R.A. (1996) Phenotype and function of human B cells expressing CD70 (CD27 ligand). European Journal of Immunology, 26, 2964-2971.
28. Adami, F., Guarini, A., Pini, M., Siviero, F., Sancetta, R., Massiai, M., Trentin, L., Foa, R. and Semenzato, G. (1994) Serum levels of tumor necrosis factor-alpha in patients with B-cell chronic lymphocytic leukaemia. European Journal of Cancer, 30A, 1259-1263.
29. Macia, J., Gomez, X. and Perez, B. (1994) Prognostic Value of Tumor Necrosis Factor in Plasma of Patients with Chronic Lymphocytic Leukemia. Blood, 84, 989-991.
30. Schultze, J.L., Cardoso, A.A., Freeman, G.F., Seamon, M.J., Daley, J., Pinkus, G.S., Gribben, J.G. and Nadler, L.M. (1995). Follicular Lymphomas Can be Induced to Present Alloantigen Efficiently: A Conceptual Model to Improve Their Tumor Immunogenicity. Proceedings of the National Academy of Sciences (USA), 92, 8200-8204.
31. Plumas, J., Chaperot, L., Jacob, M.-C., Molens, J.P., Giroux, C., Sotto, J.-J. and Bensa, J.-C. (1995) Malignant B Lymphocytes From Non-Hodgkin's Lymphoma Induce Allogeneic Proliferative and Cytotoxic T Cell Responses in Primary Mixed Lymphocyte Cultures: an Important Role of Costimulatory Molecules CD80 (B7.1)and CD86 (B7.2) in Stimulation by Tumor Cells. European Journal of Immunology, 25, 3332-3341
32. Shamash, J., Davies, D.C., Salam, A., Rohatiner, A.Z., Young, B.D. and Lister, T.A. (1995) Induction of CD80 expression in low-grade B cell lymphoma - a potential immunotherapeutic target. Leukemia, 9, 1349-1352.
33. Jeanin, P., Delneste, Y., Lecoanet-Henchoz, S., Gauchat, J.-F., Ellis, J. and Bonnefoy, J.-Y. (1997) CD86 (B7.2) on Human B cells. Journal of Biological Chemistry, 272, 15613-15619.
34. Ranheim, E.A. and Kipps, T.J. (1993) Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. Journal of Experimental Medicine, 177, 925-935.
35. Vallé, A., Aubry, J.-P., Durand, I. and Bancherau, J. (1991) IL-4 and IL-2 Upregulate the Expression of the Antigen B7, the B Cell counterstructure to T Cell CD28: an Amplification Mechanism for T-B cell Interactions. International Immunology, 3, 229-235.
36. Lahvis, G.P. and Cerny, J. (1997) Induction of Germinal Center B Cell Markers In Vitro by activated CD4+ T Lymphocytes. The Role of CD40 Ligand, Soluble Factors, and B Cell Antigen Receptor Cross-Linking. Journal of Immunology, 159, 1783-1793.
37. van Oers, M.H., Pals, S.T., Evers, L.M., van der Schoot, C.E., Koopman, G., Bonfrer, J.M., Hintzen, R.Q., von dem Borne, A.E. and van Lier, R.A. (1993) Expression and release of CD27 in human B-cell malignancies. Blood, 82, 3430-3436.
38. Lens, S.M., de Jong, R., Hintzen, R.Q., Koopman, G., van Lier, R.A. and van Oers, R.H. (1995) CD27-CD70 interaction: unraveling its implication in normal and neoplastic B-cell growth. Leukemia and Lymphoma, 18, 51-59.
39. Maurer, D., Holter, W., Majdic, O., Fischer, G.F. and Knapp, W. (1990) CD27 Expression by a Distinct Subpopulation of Human B Lymphocytes. European Journal of Immunology, 20, 2679-2684.
40. Lens, S.M., Keehnen, R.M., van Oers, M.H., van Lier, R.A., Pals, S.T. and Koopman, G. (1996) Identification of a novel subpopulation of germinal center B cells characterized by expression of IgD and CD70. European Journal of Immunology, 26, 1007-1011.
41. Agematsu, K., Nagumo, H., Oguchi, Y., Nakazawa, T., Fukushima, K., Yasui, K., Ito, S., Kobata, T., Morimoto, C. and Komiyama, A. (1998) Generation of Plasma Cells From Peripheral Blood Memory B Cells: Synergistic Effect of Interleukin-10 and CD27/CD70 Interaction. Blood, 91, 173-180.
42. Digel, W., Stefanic, M., Schoniger, W., Buck, C., Raghavachar, A., Frickhofen, N., Heimpel, H., and Porzsolt, F. (1989) Tumor necrosis factor induces proliferation of neoplastic B-Cells from chronic lymphocytic leukemia. Blood, 73, 1242-1246.
43. Brown, G.R., Meek, K., Nishioka, Y. and Thiele, D.L. (1995) CD27-CD27 ligand/CD70 interactions enhance alloantigen-induced proliferation and cytolytic activity in CD8+ T lymphocytes. Journal of Immunology, 154, 3686-3695.
44. Ramarathinam, L., Castle, M., Wu, Y. and Liu, Y. (1994) T cell Costimulation by B7/BB1 Induces CD8 T Cell-dependent Tumor Rejection: An Important,Role of B7/BB in the Induction, Recruitment, and Effector Function of Antitumor T Cells. Journal of Experimental Medicine, 179, 1205-1214.
45. Chen, L., Ashe, S., Brady, W., Hellström. I., Hellström, K.E., Ledbetter, J.A., McGowan, P. and Linsley, P.S. (1992) Costimulation of Antitumor Immunity by the B7 Counter-receptor for the T Lymphocyte Molecules CD28 and CTLA-4. Cell, 71, 1093-1102.
46. Chen, L., McGowan, P., Ashe, S., Johnston, J., Li, Y., Hellström, I. and Hellström, K.E. (1994) Tumor Immunogenicity Determines the Effect of B7 Costimulation on T Cell-mediated Tumor Immunity. Journal of Experimental Medicine, 179, 523-532.
47. Viola, A. and Lanzavecchia, A. (1996) T Cell Activation Determined by T cell Receptor Number and Tunable Thresholds. Science, 273, 104-106.